Fig. 3From: Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy modelSensitivity analyses on quality of life preferences and age. Results are based on individual level simulation (microsimulation) with 10 million trials. Time horizon = 120 years, Compliance = 100%. PCa: prostate cancer, Quality adj. LE: Quality-adjusted life expectancy, QALD: quality-adjusted life dayBack to article page